Sort
40,608 grants matching “prostate cancer”
Viral Pathogenesis of Idiopathic Bone Marrow Failure and Immune Cytopenias
$384,689Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · AI
Tyrosine Kinases and Prostate Cancer
$384,688Hsing-Jien Kung · University Of California At Davis · R01 · FY2012 · CA
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
$384,651Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Project 3: Induction of synthetic lethality with combined DNMT and PARP inhibition
$384,648Srinivasan Yegnasubramanian · Johns Hopkins University · P50 · FY2025 · CA
High speed automated intraoperative microscopy of the prostate circumference to ensure tumor-free margins in radical prostatectomy
$384,646Jonathan Quincy Brown · Tulane University Of Louisiana · R01 · FY2019 · CA
TRANSCRIPTION REGULATORY MODEL FOR ANDROGEN RECEPTOR IN PROSTATE CANCER
$384,617Dana-Farber Cancer Institute, Inc. · · FY2008 · Department of Defense
Amoeboid Membrane Dynamics in Prostate Cancer
$384,579Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2014 · CA
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
$384,576Ram Shankar Mani · Ut Southwestern Medical Center · R01 · FY2023 · CA
Vaccine and radiation for the therapy of human cancers
$384,564James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Lymphatic Imaging
$384,524Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Oklahoma Community Clinical Oncology Program (CCOP)
$384,522Warren Cancer Research Foundation · U10 · FY2004 · CA
Core-Biomarker Development Laboratory
$384,479Paul Christopher Boutros · Eastern Virginia Medical School · U2C · FY2023 · CA
Generation and utility of NADPH oxidase inhibitors
$384,435Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
Generation and utility of NADPH oxidase inhibitors
$384,435Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
The Par-4/PKCz complex in prostate cancer
$384,435Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
The Par-4/PKCz complex in prostate cancer
$384,435Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
Prostate Cancer Screening: Fostering Informed Decisions
$384,429Georgetown University · R01 · FY2003 · CA
Molecular Link Between Metabolic Syndrome and Prostate Cancer
$384,420Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2018 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$384,412John Digiovanni · University Of Texas At Austin · R01 · FY2019 · CA
Neuropilin and semaphorin, anti-angiogenesis activities and mechanisms
$384,376Michael Klagsbrun · Boston Children'S Hospital · R56 · FY2009 · CA
Analyses of human T regulatory cells
$384,357Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
MICRORNAS AS NOVEL PLASMA-BASED BIOMARKERS IN PROSTATE CANCER
$384,351Fred Hutchinson Cancer Research Center · · FY2008 · Department of Defense
Radiation Force Imaging of Prostate Cancer and Guidance of Biopsy Procedures
$384,322Kathryn R Nightingale · Duke University · R01 · FY2012 · CA
SENP:Conformational Dynamics and Inhibition by Small Molecules
$384,312Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2015 · GM
SENP:Conformational Dynamics and Inhibition by Small Molecules
$384,310Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2012 · GM